Hosted on MSN31m
15 New Drugs Selected for Medicare Price Negotiations
The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...
Santé log53m
Novo Nordisk A/S: Semaglutide 7.2 mg s.c. achieved 20.7% weight loss in the STEP UP obesity trial, and 18.7% regardless of treatment adherence
When applying the treatment policy estimand 2, people treated with semaglutide 7.2 mg achieved a superior weight loss of 18.7% compared to a reduction of 15.6% with semaglutide 2.4 mg and 3.9% with ...